SCHEMBL587611

SCHEMBL587611

CCCC(C)(C)C1CC(C(=O)O)CCN1C(=O)OC.COC(=O)N1CCC(CO)CC1CCC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3081055 0.84 NR1H2 (0.34)
SCHEMBL586904 0.83
SCHEMBL580970 0.81 LMNA (0.36)
SCHEMBL580875 0.72 NR1H2 (0.35)
SCHEMBL587242 0.70 GAA (0.34)
SCHEMBL581911 0.70 LMNA (0.38)
SCHEMBL581355 0.68 FKBP1A (0.32)
SCHEMBL3069770 0.68 GAA (0.34)
SCHEMBL587241 0.68 GAA (0.34)
SCHEMBL581442 0.68 GAA (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2417131-A1 ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS AstraZeneca AB (SE) 2012-02-15 EP disclosed
WO-2010117323-A1 METHOD AND APPARATUS FOR PRODUCING HEAT ENERGY AND CARBON DIOXIDE ASTRAZENECA AB (SE) 2010-10-14 WO disclosed